Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification-Reference-Cited by-同舟云学术

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification

Published:2015-04 Issue:2 Volume:1 Page:116-122
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Ananworanich Jintanat,Chomont Nicolas,Fletcher James L.K.,Pinyakorn Suteeraporn,Schuetz Alexandra,Sereti Irini,Rerknimitr Rungsun,Dewar Robin,Kroon Eugene,Vandergeeten Claire,Trichavaroj Rapee,Chomchey Nitiya,Chalermchai Thep,Michael Nelson L.,Kim Jerome H.,Phanuphak Praphan,Phanuphak Nittaya

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference44 articles.

1. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation;Chomont;Nat Med,2009

2. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection;Chun;Proc Natl Acad Sci U S A,1998

3. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection;Ananworanich;PLoS One,2012

4. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection;Archin;Proc Natl Acad Sci U S A,2012

5. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time;Josefsson;Proc Natl Acad Sci U S A,2013

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV RNA/DNA Levels at Diagnosis Can Predict Immune Reconstitution: A Longitudinal Analysis;Microorganisms;2023-06-06

2. Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial;Journal of Antimicrobial Chemotherapy;2022-06-28

3. Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations;Journal of Virology;2022-06-22

4. The Immunomodulatory Effects of Artesunate on Immunological Non-responders in Long-term ART-treated People Living with HIV in Selected Provinces in China: A Non-randomized Concurrent Control Trial;Pharmacological Research - Modern Chinese Medicine;2022-06

5. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies;Frontiers in Microbiology;2022-04-27